SEC Tracker
Get the app

Q32 Bio QTTB

Q32 Bio: announces exit or restructuring costs and makes a Regulation FD disclosure

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Announces exit or restructuring costs (2.05)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Q32 Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Kiora Pharmaceuticals KPRX public float $10M, Jun 30, 2025
  2. Brainstorm Cell Therapeutics BCLI public float $10M, Jun 30, 2025
  3. Scienture Holdings SCNX public float $10M, Jun 30, 2025
  4. LeonaBio ATHA public float $10M, Jun 30, 2025
  5. Mannatech MTEX public float $10M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.